BRAINEVER Trademark

Trademark Overview


On Friday, February 12, 2016, a trademark application was filed for BRAINEVER with the United States Patent and Trademark Office. The USPTO has given the BRAINEVER trademark a serial number of 79188386. The federal status of this trademark filing is CANCELLED - SECTION 71 as of Friday, December 29, 2023. This trademark is owned by BRAINEVER. The BRAINEVER trademark is filed in the Pharmaceutical Products, Medical Instrument Products, Computer & Software Services & Scientific Services, and Medical & Beauty Services & Agricultural Services categories with the following description:

Pharmaceutical products for the protection, the treatment of brain and spinal cord diseases or degenerative disorders and for improving neurological abilities, pharmaceutical compositions for the treatment of brain and spinal cord diseases or degenerative disorders; pharmaceutical products for the treatment of all cognitive deficiencies and neurodegenerative diseases; sanitary products for medical purposes, namely for the treatment of all cognitive deficiencies, neurodegenerative diseases, brain and spinal cord diseases or degenerative disorders and for improving neurological abilities; chemo-pharmaceutical products for the treatment of all cognitive deficiencies, neurodegenerative diseases, brain and spinal cord diseases or degenerative disorders and for improving neurological abilities; biological preparations for medical use, namely for the treatment of all cognitive deficiencies, neurodegenerative diseases, brain and spinal cord diseases or degenerative disorders and for improving ...

Medical care services for neurodegenerative diseases; medical care for the treatment of brain diseases; surgical treatments of the brain and spinal cord; therapy services; diagnosing and evaluating individuals with Alzheimer's disease or any other cognitive deficiency

Surgical, medical apparatus and instruments for the prevention, treatment and repair of neurodegenerative diseases; testing apparatus used for the treatment of all cognitive deficiencies and neurodegenerative diseases and for the treatment of brain and spinal cord diseases or degenerative disorders and for improving neurological abilities

Research and development of pharmaceutical products; biotechnology research and development; scientific and technological services as well as research and design services relating to the development of treatments for neurodegenerative diseases; biological research in the field of the treatment of all cognitive deficiencies and neurodegenerative diseases, and the treatment of brain and spinal cord diseases or degenerative disorders, bacteriological research in the field of the treatment of all cognitive deficiencies and neurodegenerative diseases, and the treatment of brain and spinal cord diseases or degenerative disorders, chemical research in the field of the treatment of all cognitive deficiencies and neurodegenerative diseases, and the treatment of brain and spinal cord diseases or degenerative disorders; medical and parapharmaceutical research in the field of the treatment of all cognitive deficiencies and neurodegenerative diseases, and the treatment of brain and spinal cord dise...
brainever

General Information


Serial Number79188386
Word MarkBRAINEVER
Filing DateFriday, February 12, 2016
Status709 - CANCELLED - SECTION 71
Status DateFriday, December 29, 2023
Registration Number5220280
Registration DateTuesday, June 13, 2017
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, March 28, 2017

Trademark Statements


Goods and ServicesPharmaceutical products for the protection, the treatment of brain and spinal cord diseases or degenerative disorders and for improving neurological abilities, pharmaceutical compositions for the treatment of brain and spinal cord diseases or degenerative disorders; pharmaceutical products for the treatment of all cognitive deficiencies and neurodegenerative diseases; sanitary products for medical purposes, namely for the treatment of all cognitive deficiencies, neurodegenerative diseases, brain and spinal cord diseases or degenerative disorders and for improving neurological abilities; chemo-pharmaceutical products for the treatment of all cognitive deficiencies, neurodegenerative diseases, brain and spinal cord diseases or degenerative disorders and for improving neurological abilities; biological preparations for medical use, namely for the treatment of all cognitive deficiencies, neurodegenerative diseases, brain and spinal cord diseases or degenerative disorders and for improving neurological abilities; chemical preparations for medical or pharmaceutical use, namely for the treatment of all cognitive deficiencies, neurodegenerative diseases, brain and spinal cord diseases or degenerative disorders and for improving neurological abilities; diagnostic products for medical use, namely for the treatment of all cognitive deficiencies, neurodegenerative diseases, brain and spinal cord diseases or degenerative disorders and for improving neurological abilities; medicines for human medicine for the treatment of all cognitive deficiencies, neurodegenerative diseases, brain and spinal cord diseases or degenerative disorders and for improving neurological abilities
Pseudo MarkBRAIN EVER
Goods and ServicesMedical care services for neurodegenerative diseases; medical care for the treatment of brain diseases; surgical treatments of the brain and spinal cord; therapy services; diagnosing and evaluating individuals with Alzheimer's disease or any other cognitive deficiency
Goods and ServicesSurgical, medical apparatus and instruments for the prevention, treatment and repair of neurodegenerative diseases; testing apparatus used for the treatment of all cognitive deficiencies and neurodegenerative diseases and for the treatment of brain and spinal cord diseases or degenerative disorders and for improving neurological abilities
Goods and ServicesResearch and development of pharmaceutical products; biotechnology research and development; scientific and technological services as well as research and design services relating to the development of treatments for neurodegenerative diseases; biological research in the field of the treatment of all cognitive deficiencies and neurodegenerative diseases, and the treatment of brain and spinal cord diseases or degenerative disorders, bacteriological research in the field of the treatment of all cognitive deficiencies and neurodegenerative diseases, and the treatment of brain and spinal cord diseases or degenerative disorders, chemical research in the field of the treatment of all cognitive deficiencies and neurodegenerative diseases, and the treatment of brain and spinal cord diseases or degenerative disorders; medical and parapharmaceutical research in the field of the treatment of all cognitive deficiencies and neurodegenerative diseases, and the treatment of brain and spinal cord diseases or degenerative disorders; laboratory services and scientific research services particularly in the field of genetics; medical research in the field of brain diseases; technical information services relating to medical, pharmaceutical, parapharmaceutical and surgical activities; genetic research services; planning and development (design) of technical projects in the field of genetics; research and development in the field of medicine and genetics; scientific research and development services for the protection, treatment of brain and spinal cord diseases or degenerative disorders and for improving neurological abilities; design and development of procedures and techniques for the treatment of brain and spinal cord diseases and for improving neurological abilities; clinical trials of treatments for neurodegenerative diseases, brain or spinal cord diseases, cognitive deficiencies and degenerative disorders and of diagnostic methods in the field of these diseases and genetics

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status CodeF - NOT AVAILABLE
Class Status DateFriday, December 29, 2023
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class010 - Surgical, medical, dental, and veterinary apparatus and instruments, artificial limbs, eyes, and teeth; orthopedic articles; suture materials.
US Class Codes026, 039, 044
Class Status CodeF - NOT AVAILABLE
Class Status DateFriday, December 29, 2023
Primary Code010
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status CodeF - NOT AVAILABLE
Class Status DateFriday, December 29, 2023
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class044 - Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, horticulture and forestry services.
US Class Codes100, 101
Class Status CodeF - NOT AVAILABLE
Class Status DateFriday, December 29, 2023
Primary Code044
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameBRAINEVER
Party Type30 - Original Registrant
Legal Entity Type99 - Other
AddressPARIS F75012
FR

Party NameBRAINEVER
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
AddressPARIS F75012
FR

Party NameBRAINEVER
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressPARIS F75012
FR

Trademark Events


Event DateEvent Description
Tuesday, January 10, 2017TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Thursday, July 7, 2016SN ASSIGNED FOR SECT 66A APPL FROM IB
Friday, July 8, 2016NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Friday, July 8, 2016ASSIGNED TO EXAMINER
Friday, July 8, 2016NON-FINAL ACTION WRITTEN
Saturday, July 9, 2016NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Monday, July 11, 2016REFUSAL PROCESSED BY MPU
Monday, July 11, 2016NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Tuesday, July 12, 2016APPLICATION FILING RECEIPT MAILED
Friday, July 29, 2016REFUSAL PROCESSED BY IB
Tuesday, January 10, 2017ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Thursday, February 2, 2017ASSIGNED TO EXAMINER
Wednesday, March 8, 2017NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Wednesday, March 8, 2017NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Tuesday, January 10, 2017TEAS RESPONSE TO OFFICE ACTION RECEIVED
Friday, January 27, 2017ASSIGNED TO LIE
Tuesday, January 31, 2017APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Tuesday, January 31, 2017CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, January 31, 2017TEAS/EMAIL CORRESPONDENCE ENTERED
Thursday, February 9, 2017APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, February 21, 2017LAW OFFICE PUBLICATION REVIEW COMPLETED
Wednesday, March 8, 2017NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Tuesday, March 28, 2017PUBLISHED FOR OPPOSITION
Tuesday, June 13, 2017REGISTERED-PRINCIPAL REGISTER
Wednesday, September 13, 2017FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Saturday, October 28, 2017FINAL DECISION TRANSACTION PROCESSED BY IB
Saturday, March 25, 2017NOTIFICATION PROCESSED BY IB
Tuesday, March 28, 2017OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Thursday, September 21, 2017FINAL DISPOSITION PROCESSED
Thursday, September 21, 2017FINAL DISPOSITION NOTICE SENT TO IB
Monday, June 13, 2022COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
Friday, December 29, 2023CANCELLED SECTION 71
Friday, August 30, 2024TOTAL INVALIDATION OF REG EXT PROTECTION CREATED
Friday, September 6, 2024TOTAL INVALIDATION OF REG EXT PROTECTION SENT TO IB
Sunday, September 29, 2024TOTAL INVALIDATION PROCESSED BY THE IB
Friday, September 6, 2024INVALIDATION PROCESSED